AstraZeneca’s experimental COVID-19 drug has helped cut the risk of severe disease or death in a late-stage study, the British drug maker said on Monday.British drug maker AstraZeneca has developed an antibody cocktail that is successful in treating COVID-19, its studies show.
“These positive results show that a convenient intramuscular dose of AZD7442 could play an important role in helping combat this devastating pandemic,” Hugh Montgomery, the trial’s principal investigator, said in a statement. AstraZeneca is submitting data from various AZD7442 studies to global health regulators, a spokeswoman said on Monday.“We’ll be continuing discussions with regulators around this new data,” she said of the trial results.
AZD7442 contains laboratory-made antibodies designed to linger in the body for months to contain the virus in case of an infection. A vaccine, in contrast, relies on an intact immune system to develop targeted antibodies and infection-fighting cells.
I suppose anti vaxxers will refuse that too when they are lying on their death beds
Israel Singapore failed with 2 jabs! Started so called 3rd and 4th booster jabs. Africa is doing better by taking artemisinin. India and Japan started Ivermectin! Who is collecting money from the vax ? Vax is positive related with infection! Time to have alternate treatments
5 antiviral drugs for treatment of Covid 19 Antiviral treatments that can be taken at home to keep people with COVID-19 out of the hospital are critically needed.